Platform
Features
Pricing
0 followers
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
Industries
Headquarters
Employees
Links
Bryan F. Cox
Amgen
198 followers
Revvity
4 followers
Abbott
275 followers
Integrated DNA Technologies
2 followers
10X Genomics
13 followers
Beacon Therapeutics
Charles River Laboratories
10 followers
Amyris
8 followers
Elevance Health
124 followers
Ro
33 followers
SpringWorks Therapeutics
5 followers
Explore companies